New review of the first oral PCSK9 drug, a needle-free option for high cholesterol
A new review from Binghamton University School of Pharmacy and Pharmaceutical Science explores how Lipfendra (enlicitide) can be beneficial for those who have intolerances to injectable medications. The review was recently published in Annals of Pharmacotherapy and was authored by clinical assistant professors Taylor Clark, Rachel Lucas and Mia Lussier, as well as assistant professor Azadeh…
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Thalamic responsive neurostimulation reduces seizures by over 80% in pediatric patients
United Kingdom
-
New 'FITdb' database reveals the genetic drivers of immune cell function
United Kingdom
-
Long travel distances linked to higher pediatric surgery complication risks
United Kingdom
-
Prenatal cannabis use disorder linked to higher postpartum psychiatric emergency visits
United Kingdom
-
For your health—the large and growing benefits of being smoke-free
United Kingdom
-
Drug ads can influence AI treatment recommendations, study finds
United Kingdom
-
Blocking serotonin receptors makes eye cancer cells sensitive to drugs
United Kingdom
-
Cataract surgery boosts work, income, and food security in Mozambique
United Kingdom